Advertisement

Index by author

May 01, 1986; Volume 29,Issue 5

A

  1. Adamik, R

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

  2. Allan, A M

    1. gamma-Aminobutyric acid agonists and antagonists alter chloride flux across brain membranes.
      A M Allan and R A Harris
      Molecular Pharmacology May 1986, 29 (5) 497-505;

  3. Amar, S

    1. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
      J C Bozou, S Amar, J P Vincent and P Kitabgi
      Molecular Pharmacology May 1986, 29 (5) 489-496;

B

  1. Beavo, J A

    1. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
      S A Harrison, D H Reifsnyder, B Gallis, G G Cadd and J A Beavo
      Molecular Pharmacology May 1986, 29 (5) 506-514;

  2. Bekesi, E

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

  3. Bend, J R

    1. Paraquat uptake into freshly isolated rabbit lung epithelial cells and its reduction to the paraquat radical under anaerobic conditions.
      J K Horton, R Brigelius, R P Mason and J R Bend
      Molecular Pharmacology May 1986, 29 (5) 484-488;

  4. Bozou, J C

    1. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
      J C Bozou, S Amar, J P Vincent and P Kitabgi
      Molecular Pharmacology May 1986, 29 (5) 489-496;

  5. Brigelius, R

    1. Paraquat uptake into freshly isolated rabbit lung epithelial cells and its reduction to the paraquat radical under anaerobic conditions.
      J K Horton, R Brigelius, R P Mason and J R Bend
      Molecular Pharmacology May 1986, 29 (5) 484-488;

C

  1. Cadd, G G

    1. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
      S A Harrison, D H Reifsnyder, B Gallis, G G Cadd and J A Beavo
      Molecular Pharmacology May 1986, 29 (5) 506-514;

  2. Calder, I

    1. Effect of N-hydroxyparacetamol on DNA, RNA, and protein synthesis and chromatin structure.
      N K Hayward, I Calder and M F Lavin
      Molecular Pharmacology May 1986, 29 (5) 478-483;

F

  1. Fernandes, K G

    1. The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.
      P M Lippiello and K G Fernandes
      Molecular Pharmacology May 1986, 29 (5) 448-454;

  2. Frey, E A

    1. Forskolin enhances calcium-evoked prolactin release from 7315c tumor cells without increasing the cytosolic calcium concentration.
      E A Frey, J W Kebabian and S Guild
      Molecular Pharmacology May 1986, 29 (5) 461-466;

G

  1. Gallis, B

    1. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
      S A Harrison, D H Reifsnyder, B Gallis, G G Cadd and J A Beavo
      Molecular Pharmacology May 1986, 29 (5) 506-514;

  2. Guild, S

    1. Forskolin enhances calcium-evoked prolactin release from 7315c tumor cells without increasing the cytosolic calcium concentration.
      E A Frey, J W Kebabian and S Guild
      Molecular Pharmacology May 1986, 29 (5) 461-466;

H

  1. Halpern, J L

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

  2. Harden, T K

    1. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
      L I Tanner, T K Harden, J N Wells and M W Martin
      Molecular Pharmacology May 1986, 29 (5) 455-460;

  3. Harris, R A

    1. gamma-Aminobutyric acid agonists and antagonists alter chloride flux across brain membranes.
      A M Allan and R A Harris
      Molecular Pharmacology May 1986, 29 (5) 497-505;

  4. Harrison, S A

    1. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
      S A Harrison, D H Reifsnyder, B Gallis, G G Cadd and J A Beavo
      Molecular Pharmacology May 1986, 29 (5) 506-514;

  5. Hayward, N K

    1. Effect of N-hydroxyparacetamol on DNA, RNA, and protein synthesis and chromatin structure.
      N K Hayward, I Calder and M F Lavin
      Molecular Pharmacology May 1986, 29 (5) 478-483;

  6. Horton, J K

    1. Paraquat uptake into freshly isolated rabbit lung epithelial cells and its reduction to the paraquat radical under anaerobic conditions.
      J K Horton, R Brigelius, R P Mason and J R Bend
      Molecular Pharmacology May 1986, 29 (5) 484-488;

K

  1. Kanaho, Y

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

  2. Kebabian, J W

    1. Forskolin enhances calcium-evoked prolactin release from 7315c tumor cells without increasing the cytosolic calcium concentration.
      E A Frey, J W Kebabian and S Guild
      Molecular Pharmacology May 1986, 29 (5) 461-466;

  3. Kitabgi, P

    1. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
      J C Bozou, S Amar, J P Vincent and P Kitabgi
      Molecular Pharmacology May 1986, 29 (5) 489-496;

  4. Kung, H F

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

L

  1. Lavin, M F

    1. Effect of N-hydroxyparacetamol on DNA, RNA, and protein synthesis and chromatin structure.
      N K Hayward, I Calder and M F Lavin
      Molecular Pharmacology May 1986, 29 (5) 478-483;

  2. Lippiello, P M

    1. The binding of L-[3H]nicotine to a single class of high affinity sites in rat brain membranes.
      P M Lippiello and K G Fernandes
      Molecular Pharmacology May 1986, 29 (5) 448-454;

M

  1. Martin, M W

    1. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
      L I Tanner, T K Harden, J N Wells and M W Martin
      Molecular Pharmacology May 1986, 29 (5) 455-460;

  2. Mason, R P

    1. Paraquat uptake into freshly isolated rabbit lung epithelial cells and its reduction to the paraquat radical under anaerobic conditions.
      J K Horton, R Brigelius, R P Mason and J R Bend
      Molecular Pharmacology May 1986, 29 (5) 484-488;

  3. Moss, J

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

R

  1. Rando, T A

    1. The interaction between the activator agents batrachotoxin and veratridine and the gating processes of neuronal sodium channels.
      T A Rando, G K Wang and G R Strichartz
      Molecular Pharmacology May 1986, 29 (5) 467-477;

  2. Reifsnyder, D H

    1. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
      S A Harrison, D H Reifsnyder, B Gallis, G G Cadd and J A Beavo
      Molecular Pharmacology May 1986, 29 (5) 506-514;

S

  1. Strichartz, G R

    1. The interaction between the activator agents batrachotoxin and veratridine and the gating processes of neuronal sodium channels.
      T A Rando, G K Wang and G R Strichartz
      Molecular Pharmacology May 1986, 29 (5) 467-477;

T

  1. Tanner, L I

    1. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
      L I Tanner, T K Harden, J N Wells and M W Martin
      Molecular Pharmacology May 1986, 29 (5) 455-460;

  2. Tsai, S C

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

V

  1. Vaughan, M

    1. Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
      J L Halpern, S C Tsai, R Adamik, Y Kanaho, E Bekesi, H F Kung, J Moss and M Vaughan
      Molecular Pharmacology May 1986, 29 (5) 515-519;

  2. Vincent, J P

    1. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
      J C Bozou, S Amar, J P Vincent and P Kitabgi
      Molecular Pharmacology May 1986, 29 (5) 489-496;

W

  1. Wang, G K

    1. The interaction between the activator agents batrachotoxin and veratridine and the gating processes of neuronal sodium channels.
      T A Rando, G K Wang and G R Strichartz
      Molecular Pharmacology May 1986, 29 (5) 467-477;

  2. Wells, J N

    1. Identification of the phosphodiesterase regulated by muscarinic cholinergic receptors of 1321N1 human astrocytoma cells.
      L I Tanner, T K Harden, J N Wells and M W Martin
      Molecular Pharmacology May 1986, 29 (5) 455-460;
Back to top

In this issue

Advertisement